Brepocitinib
Brepocitinib (PF-06700841) is a selective small molecule inhibitor with high potency for JAK1 and TYK2 kinases, and moderate activity against JAK2. It is widely used in preclinical research to investigate JAK/STAT signaling pathways in autoimmune and inflammatory disease models, both in vitro and in vivo.
Product Specifications
CAS Number
1883299-62-4
Product Name Alternative
Brepocitinib, Inhibitor, Janus kinase, inhibit, JAK1, JAK2, JAK3, JAK, PF-06700841, PF06700841, PF 06700841, Tyk2, Tyrosine Kinases, TyrosineKinases
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.00% (May vary between batches)
Solubility
H2O:Insoluble; DMSO:75 mg/mL (192.6 mM) ; Ethanol:75 mg/mL (192.6 mM)
Smiles
C (=O) (N1C2CN (CC1CC2) C3=NC (NC=4C=NN (C) C4) =NC=C3) [C@H]5C (F) (F) C5
Molecular Formula
C18H21F2N7O
Molecular Weight
389.4
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Phosphoserine aminotransferase (SERC)
Recombinant Human Phosphoserine aminotransferase (SERC)
Recombinant Human Phosphoserine aminotransferase (SERC)
